Pregnancy in Women With Glycogen Storage Disease Ia and Ib

Allopurinol Use during Pregnancy - Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative for Teratogenicity

(2013) Maria Hoeltzenbein et al.   PLoS One

Placental hormones and the control of maternal metabolism and fetal growth

(2013) Dorothee Newbern et al.   Current Opinion in Endocrinology Diabetes and Obesity

Pregnancy Outcome Following Exposure to Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Antagonists

(2012) Marina Bullo et al.   HYPERTENSION

Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study

(2012) Annalisa Sechi et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Potential teratogenic effects of allopurinol: A case report

(2011) Mariya Kozenko et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Natural History of Hepatocellular Adenoma Formation in Glycogen Storage Disease Type I

(2011) David Q. Wang et al.   JOURNAL OF PEDIATRICS

Antibodies to CBir1 Are Associated With Glycogen Storage Disease Type Ib

(2010) Michael K Davis et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Pregnancies in glycogen storage disease type Ia

(2008) Daniëlle H.J. Martens et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY